In January 2020, the first case of COVID-19 was reported in the US. Less than a year from the initial outbreak, in December 2020, COVID-19 vaccines were ready for Emergency Use Authorization (EUA).
The vaccine development process is arduous and can typically take five to 10 years, as we’ve encountered with well-known treatments involving conditions from polio to influenza. To provide further context behind the fast-tracked COVID-19 vaccines, we’ve broken down the important steps in the process, along with approximate timing for each clinical trial phase. Take a look to learn more.
Due to the diligence of researchers and trial participants alike, the fast-tracked timeline for the COVID-19 vaccines was made possible. If you’re interested in learning more about how Praxis is involved in the clinical trial process, visit our website or reach out today.